Probiotics and Innate and Adaptive Immune Responses in Premature Infants

Area of Science:

• Neonatal Medicine
• Microbiology
• Immunology

Background:

• Premature infants face high risks of necrotizing enterocolitis (NEC) and sepsis, leading to significant morbidity and mortality.
• Probiotics are known to reduce NEC and mortality in premature infants, but their precise mechanisms remain incompletely understood.

Purpose of the Study:

• To review the mechanisms by which probiotics confer protection against NEC and sepsis in premature infants.
• To explore the impact of various probiotic species and strains on the innate and adaptive immune responses.

Main Methods:

• Review of in vitro studies, animal models, and clinical trials evaluating probiotic efficacy in premature infants.
• Analysis of proposed protective mechanisms, including modulation of intestinal inflammation, apoptosis, dysmotility, and permeability.
• Examination of microbial competition via bacteriocin production and nutrient utilization.

Main Results:

• Probiotics demonstrate varied protective effects depending on species and strain.
• Common mechanisms include reducing intestinal inflammation, apoptosis, dysmotility, and permeability.
• Probiotics can displace pathogenic microbes and enhance nutrient absorption.

Conclusions:

• Probiotics offer a promising strategy for preventing NEC and sepsis in premature infants.
• Understanding probiotic mechanisms, particularly their influence on the immune system, is crucial for optimizing their use.
• Further research into specific strains and their immune interactions will refine therapeutic applications.